NABIL AHMED to Neoplasms
This is a "connection" page, showing publications NABIL AHMED has written about Neoplasms.
Connection Strength
0.839
-
Realism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers. Cytotherapy. 2016 11; 18(11):1382-1392.
Score: 0.179
-
Targeting the tumour profile using broad spectrum chimaeric antigen receptor T-cells. Biochem Soc Trans. 2016 Apr 15; 44(2):391-6.
Score: 0.174
-
The Evolution of T-cell Therapies for Solid Malignancies. Clin Cancer Res. 2015 Aug 01; 21(15):3384-92.
Score: 0.166
-
T-cell-based therapies for malignancy and infection in childhood. Pediatr Clin North Am. 2010 Feb; 57(1):83-96.
Score: 0.113
-
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatr Blood Cancer. 2025 Apr; 72(4):e31557.
Score: 0.080
-
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.
Score: 0.067
-
Immunogenicity of CAR T cells in cancer therapy. Nat Rev Clin Oncol. 2021 06; 18(6):379-393.
Score: 0.061